Leaflet RENAGEL 403mg capsules

Product code:
W52682001
Quantity:
60
Indicated for:
hyperphosphatemia
Route of administration:
oral
Substance:
sevelamer (phosphate binder)
ATC
V03AE02 — Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia
Sevelamer is a medication used to control hyperphosphatemia in patients with chronic kidney disease on dialysis. It works by binding to dietary phosphates in the gastrointestinal tract, reducing their absorption and serum phosphate levels.

The medication is taken orally, as directed by a doctor, usually with meals. It is important for patients to follow the treatment regimen and adhere to a low-phosphate diet.

Patients should be aware of potential side effects, such as gastrointestinal disturbances, nausea, or constipation. It is important to inform the doctor of any unusual symptoms.

Common side effects include gastrointestinal disturbances, nausea, and constipation. In rare cases, severe reactions such as intestinal obstruction or gastrointestinal perforation may occur. Patients should be informed of these risks before starting treatment.

General data about RENAGEL 403mg

Substance:
sevelamer
Date of latest medicines list:
01-07-2013
Product code:
W52682001
Concentration:
403mg
Pharmaceutical form:
capsules
Quantity:
60
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for sevelamer

Concentrations available for sevelamer

  • 1.6g
  • 2.4g
  • 400mg
  • 403mg
  • 800mg